<DOC>
	<DOC>NCT00195611</DOC>
	<brief_summary>The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.</brief_summary>
	<brief_title>Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Otitis Media with Effusion</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Infants aged from 6 to 24 months Presenting with AOM (ear infection) Patients must not have received any antibiotic therapy within the past 7 days. Other inclusion applies.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Middle Ear Infection</keyword>
</DOC>